Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$1.76 - $2.83 $2.64 Million - $4.25 Million
-1,500,000 Reduced 80.18%
370,839 $938,000
Q1 2023

May 15, 2023

BUY
$2.13 - $3.6 $789,887 - $1.34 Million
370,839 Added 24.72%
1,870,839 $4.77 Million
Q4 2022

Feb 14, 2023

SELL
$2.05 - $3.47 $760,219 - $1.29 Million
-370,839 Reduced 19.82%
1,500,000 $3.76 Million
Q3 2022

Nov 14, 2022

SELL
$0.63 - $5.47 $137,214 - $1.19 Million
-217,800 Reduced 10.43%
1,870,839 $5.43 Million
Q2 2022

Aug 15, 2022

SELL
$4.27 - $8.26 $7.76 Million - $15 Million
-1,818,131 Reduced 46.54%
2,088,639 $9.44 Million
Q1 2022

May 16, 2022

SELL
$7.07 - $11.62 $1.67 Million - $2.74 Million
-236,000 Reduced 5.7%
3,906,770 $31.3 Million
Q4 2021

Feb 14, 2022

BUY
$10.49 - $14.28 $1.79 Million - $2.43 Million
170,500 Added 4.29%
4,142,770 $48.2 Million
Q3 2021

Nov 15, 2021

BUY
$9.94 - $12.77 $39.5 Million - $50.7 Million
3,972,270 New
3,972,270 $49.2 Million

Others Institutions Holding SLGC

About SomaLogic, Inc.


  • Ticker SLGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 183,452,992
  • Description
  • SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...
More about SLGC
Track This Portfolio

Track Redmile Group, LLC Portfolio

Follow Redmile Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redmile Group, LLC with notifications on news.